Generex Biotechnology Corporation is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device.
Gross profit (Q3, 2019)
Gross profit margin (Q3, 2019), %
Net income (Q3, 2019)
EBIT (Q3, 2019)
Market capitalization (31-Oct-2017)
Closing stock price (31-Oct-2017)
|USD||Q3, 2014||Q1, 2016||Q2, 2016||Q3, 2016||Q3, 2017||Q1, 2018||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019||Q3, 2019|
Depreciation and Amortization
Generex Biotechnology has 525 Twitter Followers. The number of followers has increased 0.6% month over month and increased 2.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
How many employees does Generex Biotechnology have?
Generex Biotechnology has 3 employees.
What is Generex Biotechnology revenue?
Latest Generex Biotechnology annual revenue is $703.2 k.
What is Generex Biotechnology revenue per employee?
Latest Generex Biotechnology revenue per employee is $234.4 k.
Who are Generex Biotechnology competitors?
Competitors of Generex Biotechnology include Vitality Biopharma, Opiant Pharmaceuticals and Mylan.
Where is Generex Biotechnology headquarters?
Generex Biotechnology headquarters is located at 4145 N Service Rd, Burlington.
Where are Generex Biotechnology offices?
Generex Biotechnology has an office in Burlington.
How many offices does Generex Biotechnology have?
Generex Biotechnology has 1 office.
Receive alerts for 300+ data fields across thousands of companies